Tert-butyl-propylether (stabilized with BHT), 95.0%, 250mg

2-Methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole>98.0%(GC)(T)200mg

ETHYL 4-CHLORO-6-NITROQUINOLINE-3-CARBOXYLATE, 97.0%, 100mg

2,4-Dichloroaniline>99.0%(GC)500g

N-Methyl-1-(pyrrolidin-2-yl)methanamine dihydrochloride, 96%, 1g

(S)-3-(tert-Butoxycarbonyl)-2,2-dimethyloxazolidine-4-carboxylic acid, 95.0%, 25g

7-Aminoquinoxalin-2(1H)-one, 95.0%, 250mg

(R)-2-(3-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)THIOUREIDO)-N-(2,4-DIFLUOROPHENYL)-2-PHENYLACETAMIDE, 95%, 50mg

N-(2-methoxyethyl)-2-piperazin-1-ylacetamide, 250mg

H-Trp-Gly-OH, 95%, 1g

(S)-ethyl 2-amino-4-fluoro-4-methylpentanoate, 98%, 100mg

Levomefolic Acid>98.0%(HPLC)250mg

2,6-Bis(trimethylstannyl)-4,8-bis[(2-n-octyldodecyl)oxy]benzo[1,2-b:4,5-b']dithiophene>95.0%(HPLC)200mg